COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/...

ID 39114911000001105
ConceptGeneric COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials
Name COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials
Abbreviated name COVID-19 Vaccine Vaxzevria 0.5ml inj multidose vials
Description COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)
Date of name applicability 10 May 2022
Previous Name COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose suspension for injection multidose vials
SupplierAstraZeneca UK Ltd
Licensed asMedicines - MHRA/EMA
Previously licensed asNone
License change reasonLicence Granted
Date of change of licensing authority 5 Jan 2021
EMA (European Medicines Agency) Monitoring 1
Restrictions on availabilityRestricted Availability
Licensed routeIntramuscular